Citadel Advisors - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 51 filers reported holding SYNTHETIC BIOLOGICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2018$28,000
-77.0%
117,512
-51.4%
0.00%
Q4 2017$122,000
+121.8%
241,797
+312.1%
0.00%
Q3 2017$55,000
+41.0%
58,677
+169.7%
0.00%
Q2 2016$39,000
+21.9%
21,755
+61.0%
0.00%
Q1 2016$32,000
-66.3%
13,510
-67.8%
0.00%
Q3 2015$95,000
-60.9%
41,922
-50.8%
0.00%
Q2 2015$243,000
+24200.0%
85,173
+12315.9%
0.00%
Q4 2014$1,000
-96.4%
686
-95.6%
0.00%
Q3 2014$28,000
-15.2%
15,688
-18.4%
0.00%
Q2 2014$33,000
-68.6%
19,231
-53.0%
0.00%
Q1 2014$105,00040,9000.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Third Security, LLC 13,238,268$6,726,0000.58%
MSD Partners, L.P. 4,118,402$2,092,0000.11%
683 Capital Management, LLC 1,500,000$762,0000.06%
Vivaldi Capital Management LP 101,145$51,0000.04%
Alyeska Investment Group, L.P. 5,000,000$2,540,0000.02%
BARD ASSOCIATES INC 56,499$29,0000.01%
FRANKLIN STREET ADVISORS INC /NC 126,000$64,0000.01%
Virtu Financial LLC 299,577$152,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 46,981$24,0000.01%
Stanley-Laman Group, Ltd. 60,323$31,0000.01%
View complete list of SYNTHETIC BIOLOGICS INC shareholders